Total investments 41
Average round size 
$137M
The average size of a deal this fund participated in
Portfolio companies 37
Lead investments 9
Follow on index
0.10How often the fund supports its portfolio startups at next rounds
Exits 16
Key employees Soon
Palo Alto, California, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of TCG Crossover:
Typical Co-investors
TCG Crossover is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after TCG Crossover:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Alexa Fund | Seattle, United States, Washington |
| Archimedes Labs | California, Palo Alto, United States |
| Asheville Angels | Asheville, North Carolina, United States |
| BOND | New York, New York, United States |
| Brio Capital Management | New York, New York, United States |
| Candy Ventures | Luxembourg, Luxembourg |
| Cboe FX Markets | New York, New York, United States |
| Crabtree & Evelyn | Connecticut, United States, Woodstock |
| Derbi Foundation | Bangalore, India, Karnataka |
| Emergent Game Technologies | Calabasas, California, United States |
| Gray Ventures | Atlanta, Georgia, United States |
| iDo Fund | - |
| Industrial Bank | China, Foochow, Fujian |
| Momo | Beijing, Beijing, China |
| Motian Star | China, Guangdong, Shenzhen |
| Pentech Ventures | City of Edinburgh, Scotland, United Kingdom |
| Puget Sound Venture Club | Bellevue, United States, Washington |
| Qianhai Zhongwei Capital | China, Guangdong, Shenzhen |
| Shenshang Xingye Fund | - |
| Slack Venture Capital | England, Nottingham, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Obsidian Therapeutics | $160M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Mirador Therapeutics | $400M | 21 Mar 2024 | San Diego, California, United States | ||
ADARx Pharmaceuticals | $200M | 09 Aug 2023 | San Diego, California, United States | ||
Upstream Bio | $200M | 08 Jun 2023 | Waltham, Massachusetts, United States | ||
Alkeus Pharmaceuticals | $150M | 05 Jun 2023 | Boston, Massachusetts, United States | ||
Tourmaline Bio | $112M | 01 Jan 2023 | New York, New York, United States | ||
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
Upstream Bio | $200M | 02 Jun 2022 | Waltham, Massachusetts, United States | ||
Plexium | $102M | 23 Feb 2022 | San Diego, California, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent TCG Crossover?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 41
Average round size 137M
Peak activity year 2023
Lead investments 9
Follow on index 0.10
Exits 16
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Obsidian Therapeutics | $160M | 03 Apr 2024 | Cambridge, Massachusetts, United States | ||
Mirador Therapeutics | $400M | 21 Mar 2024 | San Diego, California, United States | ||
ADARx Pharmaceuticals | $200M | 09 Aug 2023 | San Diego, California, United States | ||
Upstream Bio | $200M | 08 Jun 2023 | Waltham, Massachusetts, United States | ||
Alkeus Pharmaceuticals | $150M | 05 Jun 2023 | Boston, Massachusetts, United States | ||
Tourmaline Bio | $112M | 01 Jan 2023 | New York, New York, United States | ||
Aktis Oncology | $84M | 25 Aug 2022 | Boston, Massachusetts, United States | ||
Upstream Bio | $200M | 02 Jun 2022 | Waltham, Massachusetts, United States | ||
Plexium | $102M | 23 Feb 2022 | San Diego, California, United States |
